Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Microabluminuria in arterial hypertension. Measurement, variables, interpretation, recommendations].

A Hornych1, M Marre, A Mimran

  • 1Service de néphrologie, hôpital Broussais, 96, rue Didot, 75674 Paris.

Archives Des Maladies Du Coeur Et Des Vaisseaux
|February 24, 2001
PubMed
Summary

Microalbuminuria, an early sign of kidney damage in hypertension, indicates increased cardiovascular risk. Its measurement is crucial for assessing this risk in hypertensive patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Left ventricular function in hypertension without left ventricular hypertrophy: echographic study with modelisation of left ventricular-aortic coupling].

Annales de cardiologie et d'angeiologie·2014
Same author

Can we identify response markers to antihypertensive drugs? First results from the IDEAL Trial.

Journal of human hypertension·2014
Same author

Office and ambulatory pulse pressure--association with clinical characteristics and cardiovascular risk factors in normoalbuminuric patients with type 2 diabetes (ROADMAP study).

Journal of human hypertension·2010
Same author

Detection of paroxysmal atrial fibrillation with transtelephonic EKG in TIA or stroke patients.

Neurology·2010
Same author

Efficacy of a potential trivalent vaccine based on Hc fragments of botulinum toxins A, B, and E produced in a cell-free expression system.

Clinical and vaccine immunology : CVI·2010
Same author

Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study.

Diabetologia·2009

Area of Science:

  • Nephrology
  • Cardiology
  • Hypertension Research

Context:

  • Permanent hypertension often presents with early-stage increased glomerular permeability to albumin, signaling renal involvement and endothelial dysfunction.
  • Microalbuminuria is defined as urinary albumin excretion of 30-300 mg/24 hours, confirmed over three months.
  • Prevalence is 5-8% in the general population and 6-24% in hypertensive individuals.

Purpose:

  • To define microalbuminuria and its measurement methods.
  • To highlight its significance as a marker of cardiovascular and renal risk in hypertensive patients.
  • To discuss clinical recommendations for its detection and measurement in various contexts.

Summary:

  • Microalbuminuria, characterized by specific urinary albumin excretion levels, can be accurately measured using sensitive radio-immunological, immunonephelometric, and Elisa methods.

Related Experiment Videos

  • High intra-individual variability necessitates consistent measurement techniques and repeat testing.
  • Its presence in hypertensive patients signifies heightened cardiovascular and renal risk, guiding clinical management and research.

    • Impact:

    • Microalbuminuria measurement serves as a vital clinical research tool for evaluating cardiovascular and renal risk in hypertension.
    • Early detection and monitoring can inform therapeutic strategies and improve patient outcomes.
    • Further studies on antihypertensive drug effects on microalbuminuria are recommended for better risk assessment.